Rytary ER 48.75 MG-195 MG cap 100S
Ended Awarded
- Contract number
- SPE2DB25FGAJP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,103
Award facts
- Contract value 100% obligated
- $2,102.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,102.87 to AmerisourceBergen Drug Corp for RYTARY ER 48.75 mg–195 mg capsules (100 count) on July 31, 2025, with completion scheduled for August 1, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
RYTARY is a carbidopa-levodopa extended-release medication used in Parkinson's disease treatment. This delivery order fulfills a specific pharmaceutical need within the Defense Health Agency's medical supply chain, reflecting AmerisourceBergen's critical role as a major pharmaceutical distributor supporting federal military and veteran healthcare systems. AmerisourceBergen's extensive portfolio of federal contracts with DLA demonstrates the company's capability to meet competitive procurement requirements across diverse therapeutic domains, including specialty medications, vaccines, and medical supplies distributed globally to support U.S. military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FGAJP?
SPE2DB25FGAJP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 31, 2025.
How much is contract SPE2DB25FGAJP worth?
The government has obligated $2,103 on SPE2DB25FGAJP.
Is contract SPE2DB25FGAJP an order under another contract?
Yes. SPE2DB25FGAJP is a delivery order under SPE2DB24D3015, an indefinite delivery contract.
Was contract SPE2DB25FGAJP competed?
The extent of competition for SPE2DB25FGAJP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award